Analystreport

Seres Therapeutics (NASDAQ:MCRB) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com